233
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Dexmedetomidine modulates mitochondrial dynamics to protect against endotoxin-induced lung injury via the protein kinase C-ɑ/haem oxygenase-1 signalling pathway

ORCID Icon, , , , , , & ORCID Icon show all
Pages 159-168 | Received 18 Jun 2021, Accepted 21 Dec 2021, Published online: 18 Jan 2022

References

  • Alparslan, T., et al., 2020. Dexmedetomidine for reduction of atrial fibrillation and delirium after cardiac surgery (DECADE): a randomised placebo-controlled trial. The Lancet, 396, 177–185.
  • Brown, M.P., et al., 2010. Regulation of mitochondrial biogenesis. Essays in Biochemistry, 47, 69–84.
  • Cecconi, M., et al., 2018. Sepsis and septic shock. Lancet, 392 (10141), 75–87.
  • Chen, Y., Bian, W., and Xu, B., 2020. Pretreatment with dexmedetomidine alleviates lung injury in a rat model of intestinal ischemia reperfusion. Molecular Medicine Reports, 21, 1233–1241.
  • Cheng, K.T., et al., 2017. Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury . The Journal of Clinical Investigation, 127 (11), 4124–4135.
  • Cho, R.L., et al., 2018. Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammation. Biochemical Pharmacology, 148, 222–237.
  • Cloonan, S.M., et al., 2020. Mitochondrial dysfunction in lung ageing and disease. European Respiratory Review, 29 (157), 200165.
  • David, S., et al., 2015. Impact of chemically-modified tetracycline 3 on intertwined physiological, biochemical, and inflammatory networks in porcine sepsis/ARDS. International Journal of Burns and Trauma, 5, 22–35.
  • Eddy, F., et al., 2018. Acute respiratory distress syndrome advances in diagnosis and treatment. JAMA, 319 (7), 698–710.
  • Englert, J.A., et al., 2019. Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome. JCI Insight, 4 (2), e124061.
  • Fan, E., et al., 2018. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA, 319 (7), 698.
  • Fu, C., et al., 2017. Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats . Molecular Medicine Reports, 15 (1), 131–138.
  • Funes, S.C., et al., 2020. Naturally derived heme-oxygenase 1 inducers and their therapeutic application to immune-mediated diseases. Frontiers in Immunology, 11, 1467.
  • Gao, S., et al., 2015. Effects of dexmedetomidine pretreatment on heme oxygenase-1 expression and oxidative stress during one-lung ventilation. International Journal of Clinical and Experimental Pathology, 8 (3), 3144–3149.
  • Han, B., et al., 2011. Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury . Intensive Care Medicine, 37 (2), 334–342.
  • Jennifer, L., et al., 2020. Mitochondrial quality control in pulmonary fibrosis. Redox Biology, 33, 101426.
  • Kaleli, H.N., et al., 2020. Protein kinase C isozymes and autophagy during neurodegenerative disease progression. Cells, 9 (3), 553.
  • Keating, G.M., 2015. Dexmedetomidine: a review of its use for sedation in the intensive care setting. Drugs, 75 (10), 1119–1130.
  • Kim, K.M., et al., 2016. Coniferaldehyde inhibits LPS-induced apoptosis through the PKC α/β II/Nrf-2/HO-1 dependent pathway in RAW264.7 macrophage cells. Environmental Toxicology and Pharmacology, 48, 85–93.
  • Li, J., et al., 2018. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α2AR/PI3K/Akt pathway. Journal of Translational Medicine, 16(1), 78.
  • Li, X., et al., 2018. Activation of protein kinase C-α/heme oxygenase-1 signaling pathway improves mitochondrial dynamics in lipopolysaccharide-activated NR8383 cells. Experimental and therapeutic medicine, 16 (2), 1529–1537.
  • MacGarvey, N.C., et al., 2012. Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. American Journal of Respiratory and Critical Care Medicine, 185 (8), 851–861.
  • Matthay, M.A., et al., 2019. Acute respiratory distress syndrome. Nature reviews. Disease Primers, 5 (1), 18–22.
  • Mehrdad, G., et al., 2020. The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis. Apoptosis, 25, 674–685.
  • Mehta, J., Rayalam, S., and Wang, X., 2018. Cytoprotective effects of natural compounds against oxidative stress. Antioxidants, 7(10), 147.
  • Mishra, P. and Chan, D., 2014. Mitochondrial dynamics and inheritance during cell division, development and disease. Nature reviews. Molecular Cell Biology, 15 (10), 634–646.
  • Mishra, P., et al., 2014. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell metabolism, 19 (4), 630–641.
  • Ohta, Y., et al., 2020. Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial. Critical Care, 24 (1), 493.
  • Pandharipande, P.P., et al., 2007. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA, 298 (22), 2644–2653.
  • Puthucheary, Z.A., et al., 2018. Metabolic phenotype of skeletal muscle in early critical illness. Thorax, 73 (10), 926–935.
  • Qiao, H., et al., 2009. Sedation improves early outcome in severely septic Sprague Dawley rats. Critical care, 13 (4), R136.
  • Riker, R.R., 2009. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA, 301 (5), 489–499.
  • Rudd, K.E., et al., 2020. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet, 395 (10219), 200–211.
  • Ryter, S.W., 2019. Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammation. Archives of Biochemistry and Biophysics, 678, 108186.
  • Savino, S., et al., 2019. Biomarkers for acute respiratory distress syndrome and prospects for personalised medicine. Journal of inflammation, 16 (1), 1.
  • Shankar, H.M., Fan, E., and Ferguson, N.D., 2019. Acute respiratory distress syndrome (ARDS) phenotyping. Intensive care medicine, 45 (4), 516–519.
  • Shi, J., et al., 2018. Phosphatidylinositol 3-kinase-mediated HO-1/CO represses Fis1 levels and alleviates lipopolysaccharide-induced oxidative injury in alveolar macrophages. Experimental and Therapeutic Medicine, 16 (3), 2735–2742.
  • Shi, J., et al., 2019. PI3K/Akt pathway-mediated HO-1 induction regulates mitochondrial quality control and attenuates endotoxin-induced acute lung injury. Laboratory Investigation, 99 (12), 1795–1809.,
  • Shi, J., et al., 2021. Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway. Redox Biology, 41, 101954– 101914.
  • Stuart, A., et al., 2005. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. Journal of Immunology, 175, 4408–4415.
  • Su, Y., et al., 2021. Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): current understanding and future perspectives. Journal of Leukocyte Biology, 110 (1), 27–38.
  • Taniguchi, T., et al., 2008. Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. Journal of Anesthesia, 22 (3), 221–228.
  • Vettorazzi, S., et al., 2015. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nature Communications, 6, 7796.
  • Wang, X.L., et al., 2018. Endogenous hydrogen sulfide ameliorates NOX4 induced oxidative stress in LPS-stimulated macrophages and mice. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 47 (2), 458–474.
  • Wang, Y., et al., 2019. Dexmedetomidine alleviates LPS-induced apoptosis and inflammation in macrophages by eliminating damaged mitochondria via PINK1 mediated mitophagy. International Immunopharmacology, 73, 471–481.
  • Wang, Y.M., et al., 2020. Protective and predictive role of Mucin1 in sepsis-induced ALI/ARDS. International Immunopharmacology, 83, 106438–106439.
  • Waza, A.A., et al., 2018. A review on heme oxygenase-1 induction: is it a necessary evil. Inflammation Research, 67 (7), 579–588.
  • Wepler, M., et al., 2019. Impaired glucocorticoid receptor dimerization aggravates LPS-induced circulatory and pulmonary dysfunction. Frontiers in Immunology, 10, 3152.
  • Wu, Y., et al., 2013. Dexmedetomidine inhibits inflammatory reaction in lung tissues of septic rats by suppressing TLR4/NF-κB pathway. Mediators of Inflammation, 2013, 562154–562159.
  • Xiang, H., et al., 2014. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Inflammation, 37 (5), 1763–1770.
  • Xu, L., et al., 2013. Effects of dexmedetomidine on early and late cytokines during polymicrobial sepsis in mice. Inflammation Research, 62 (5), 507–514..
  • Xue, B.B., et al., 2019. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway. The Kaohsiung Journal of Medical Sciences, 35 (11), 672–678.
  • Yang, C.M., et al., 2020. Mevastatin-induced AP-1-dependent HO-1 expression suppresses vascular cell adhesion molecule-1 expression and monocyte adhesion on human pulmonary alveolar epithelial cells challenged with TNF-α. Biomolecules, 10 (3), 381.
  • Yang, Q., et al., 2019. The role of tyrosine phosphorylation of protein kinase C delta in infection and inflammation. International Journal of Molecular Sciences, 20 (6), 1498.
  • Yu, J.B., et al., 2016. Heme oxygenase-1/carbon monoxide-regulated mitochondrial dynamic equilibrium contributes to the attenuation of endotoxin-induced acute lung injury in rats and in lipopolysaccharide-activated macrophages. Anesthesiology, 125 (6), 1190–1201.
  • Zhang, J., et al., 2015. The effect of dexmedetomidine on inflammatory response of septic rats. BMC Anesthesiology, 15, 68.
  • Zhang, J.R., et al., 2019. Dexmedetomidine attenuates lung injury by promoting mitochondrial fission and oxygen consumption. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 25, 1848–1856.
  • Zhang, Y., et al., 2017. Dexmedetomidine may upregulate the expression of caveolin‐1 in lung tissues of rats with sepsis and improve the short‐term outcome. Molecular Medicine Reports, 15 (2), 635–642.
  • Zhang, Y., et al., 2018. Dexmedetomidine mitigate acute lung injury by inhibiting IL-17-induced inflammatory reaction. Immunobiology, 223 (1), 32–37.
  • Zhao, W., et al., 2018. Taurine enhances the protective effect of dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system . Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 103, 1362–1368.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.